A Phase 1b Study to Assess the Safety and Anti-tumour Activity of Dexanabinol Monotherapy and Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2016
At a glance
- Drugs Dexanabinol (Primary) ; Gemcitabine; Paclitaxel; Sorafenib
- Indications Liver cancer; Pancreatic cancer
- Focus Adverse reactions
- Sponsors e-Therapeutics
- 22 Mar 2016 Status changed from recruiting to completed, according to an e-Therapeutics media release.
- 19 May 2015 The first patient has been enrolled and has received an initial dose, according to an e-Therapeutics media release.
- 22 Apr 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.